|
FBXO11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.00480000000547E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.224700E-04 |
| Normal-vs-Stage2 |
6.264100E-03 |
| Normal-vs-Stage3 |
1.93162999999608E-05 |
| Normal-vs-Stage4 |
2.10330000000036E-05 |
| Stage1-vs-Stage2 |
6.490800E-01 |
| Stage1-vs-Stage3 |
6.331800E-02 |
| Stage1-vs-Stage4 |
7.438500E-02 |
| Stage2-vs-Stage3 |
4.324600E-01 |
| Stage2-vs-Stage4 |
4.297200E-01 |
| Stage3-vs-Stage4 |
9.307400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79665999999745E-05 |
| Normal-vs-AfricanAmerican |
1.594600E-01 |
| Normal-vs-Asian |
1.144220E-02 |
| Caucasian-vs-AfricanAmerican |
1.554810E-01 |
| Caucasian-vs-Asian |
1.979630E-01 |
| AfricanAmerican-vs-Asian |
6.918000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.755200E-03 |
| Normal-vs-Female |
3.73280000000031E-05 |
| Male-vs-Female |
1.518210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.902920E-03 |
| Normal-vs-Age(41-60Yrs) |
1.410860E-04 |
| Normal-vs-Age(61-80Yrs) |
6.42920000000213E-05 |
| Normal-vs-Age(81-100Yrs) |
2.596300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.142800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.497190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.681200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.434400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.102000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.918000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.438600E-03 |
| Classical-VS-Follicular |
8.039600E-01 |
| Classical-VS-Other |
7.730400E-01 |
| Classical-VS-Normal |
6.753800E-04 |
| Tall-VS-Follicular |
3.060400E-02 |
| Tall-VS-Other |
2.522600E-01 |
| Tall-VS-Normal |
4.44369999996752E-06 |
| Follicular-VS-Other |
8.887200E-01 |
| Follicular-VS-Normal |
5.519400E-03 |
| Other-VS-Normal |
1.007450E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.89249999999319E-05 |
| Normal-vs-N1 |
7.67690000000876E-05 |
| N0-vs-N1 |
3.746000E-01 |
|
|
